Vorinostat (rINN) also known as suberanilohydroxamic acid is a member of a larger class of compounds that inhibit histone deacetylases (HDAC).
Drug information on Vorinostat for patients and consumers.
Vorinostat (Zolinza) chemotherapy side effects, how it's given, how it works, precautions and self care tips for treatment of cutaneous T-cell lymphoma.
Jul 3, 2013 ... On October 6, 2006, the U.S. Food and Drug Administration granted approval to vorinostat (Zolinza™, Merck & Co., Inc.), a histone deacetylase ...
Vorinostat also known as SAHA, Zolinza, MK-0683 is an HDAC inhibitor. Vorinostat CAS No 149647-78-9 with purity >99% & solubility DMSO is available.
Jun 16, 2017 ... Vorinostat is a white to light orange powder. It is very slightly soluble in water, slightly soluble in ethanol, isopropanol and acetone, freely ...
Sep 28, 2017 ... Vorinostat is in a class of anti-cancer therapies called histone deacetylase ( HDAC) inhibitors. Histone deacetylation is a biochemical process ...
Dec 12, 2006 ... Vorinostat (suberoylanilide hydroxamic acid or SAHA) is a nanomolar inhibitor of HDAC activity that has undergone initial evaluation in multiple ...
Vorinostat is a member of the hydroxamic acid subclass of histone deacetylase ( HDAC) inhibitors. Its primary biochemical mechanism is to correct an aberrant ...